Alnylam Pharmaceuticals, Inc. (OQ:ALNY)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

INK Ultra Money Premium

Get a Canadian Insider Club Ultra subscription for

  • Insider filing email alerts
  • Access to premium INK Research reports
  • Full access to weekly North America Top filer reports
  • Ad-free browsing
  • INK Ultra Money premium content

(already an Ultra member? Please log into your account for access)

Latest 10 SEC filings (by transaction date) for ALNY within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 15th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 13/19 Dec 12/19 Greenstreet Yvonne Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -3,208 $120.61
Dec 13/19 Dec 12/19 Greenstreet Yvonne Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 7,500  
Nov 26/19 Nov 22/19 Greene Barry E Direct Ownership Performance Stock Option 2017 (right to buy) A - Grant, award or other under Rule 16b-3(d) 9,999  
Nov 26/19 Nov 22/19 Keating Laurie Direct Ownership Performance Stock Option 2017 (right to buy) A - Grant, award or other under Rule 16b-3(d) 4,583  
Nov 26/19 Nov 22/19 Greenstreet Yvonne Direct Ownership Performance Stock Option 2017 (right to buy) A - Grant, award or other under Rule 16b-3(d) 8,333  
Nov 26/19 Nov 22/19 Maraganore John Direct Ownership Performance Stock Option 2017 (right to buy) A - Grant, award or other under Rule 16b-3(d) 17,498  
Nov 26/19 Nov 22/19 Vaishnaw Akshay Direct Ownership Performance Stock Option 2017 (right to buy) A - Grant, award or other under Rule 16b-3(d) 8,333  
Nov 22/19 Nov 20/19 Fanucci Marsha Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -15,000  
Nov 22/19 Nov 20/19 Fanucci Marsha Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -15,000  
Nov 22/19 Nov 20/19 Fanucci Marsha Direct Ownership Non-Qualified Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -15,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ALNY within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 15th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 13/19 Dec 12/19 Greenstreet Yvonne Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -3,208 $120.61
Dec 13/19 Dec 12/19 Greenstreet Yvonne Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 7,500  
Nov 26/19 Nov 22/19 Greene Barry E Direct Ownership Performance Stock Option 2017 (right to buy) A - Grant, award or other under Rule 16b-3(d) 9,999  
Nov 26/19 Nov 22/19 Keating Laurie Direct Ownership Performance Stock Option 2017 (right to buy) A - Grant, award or other under Rule 16b-3(d) 4,583  
Nov 26/19 Oct 10/19 Keating Laurie Indirect Ownership Common Stock J - Other transaction 10  
Nov 26/19 Nov 22/19 Greenstreet Yvonne Direct Ownership Performance Stock Option 2017 (right to buy) A - Grant, award or other under Rule 16b-3(d) 8,333  
Nov 26/19 Nov 22/19 Maraganore John Direct Ownership Performance Stock Option 2017 (right to buy) A - Grant, award or other under Rule 16b-3(d) 17,498  
Nov 26/19 Nov 22/19 Vaishnaw Akshay Direct Ownership Performance Stock Option 2017 (right to buy) A - Grant, award or other under Rule 16b-3(d) 8,333  
Nov 22/19 Nov 20/19 Fanucci Marsha Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -15,000  
Nov 22/19 Nov 20/19 Fanucci Marsha Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -15,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ALNY

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Vir Biotechnology (OQ:VIR)
Seattle Genetics (OQ:SGEN)